Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma

Immune checkpoint inhibitors (ICIs) are widely used in both monotherapy and combination chemotherapy for various types of cancers. Nivolumab is the most popular among ICIs, and the number of adapted malignant diseases for nivolumab is increasing. Bronchoesophageal fistula formation is a serious comp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oxf Med Case Reports
Hlavní autoři: Nishiyama, Akihiro, Sakaguchi, Hiroyuki, Yanagimura, Naohiro, Suzuki, Chiaki, Otani, Sakiko, Tanimoto, Azusa, Yamashita, Kaname, Takeuchi, Shinji, Ohtsubo, Koushiro, Ikeda, Hiroko, Yano, Seiji
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768526/
https://ncbi.nlm.nih.gov/pubmed/33391772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky